Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by CCAbbott888on Apr 26, 2019 2:03pm
76 Views
Post# 29675899

RE:RE:RE:RE:20.72Milliard d’action en circulation et 1.45milliard de cap

RE:RE:RE:RE:20.72Milliard d’action en circulation et 1.45milliard de cap
peasoupfog wrote: Jacques4444, you are assuming that Consonance Capital will not exercise their Rights on their 3 billion shares. Can we get that confirmed by some link or in black and white somewhere? If the do exercise their Rights we will only get about 1.25 shares for each one we own. Not the 6.66-20 that you mention. I will only do it if they don’t....

peasoupfog  as I told someone earlier, Consonance, through the recent pp, becomes the second largest PLI tute investor (next to SALP). 

However, it is not a normal practice for the third party to disclose what their own investment stragegy is (i.e. Consonance has no obligation to disclose to SALP, Prometic, or Prometic's retailers what they will do if their 3.3B prometic stocks are also eligible for the rights offer).

In the rights offer, I think that each eligible share holder indicate how many shares (up to x20) they wish to buy and then the company will let them know once the offer is closed and subscribed share number totalled, or if needed, pro-rated. 

It seems to me that your condition for waiting on Consonance's disclosure before you'll take part in the rights offer may prove a difficult (if not impossible) one to meet. 

Bullboard Posts